On September 26, 2023, Forte Biosciences Inc announced that it held its 2023 annual meeting of shareholders on September 19, 2023 and declared the voting results. Accordingly, nomination made by Camac Partners LLC to nominate Michael Hacke and Chris McIntyre were not appointed, nominations made by the Company to nominate Lawrence Eichenfield and Paul A. Wagner were appointed as directors to the Company board, a proposal made by the Company to approve, on an advisory basis, the compensation of the Company?s named executive officers was not approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.725 USD | +1.21% | +0.69% | -11.77% |
Mar. 18 | Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Camac Partners Provides Information to Shareholders | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.77% | 26.07M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Declaration of Voting Results by Forte Biosciences